Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 13:17:E14.
doi: 10.5888/pcd17.190263.

Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department

Affiliations

Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department

Bernadette Jakeman et al. Prev Chronic Dis. .

Abstract

Introduction: The objective of this study was to evaluate a novel collaborative care model using community pharmacies as additional access points for latent tuberculosis infection (LTBI) treatment for patients using combination weekly therapy with isoniazid and rifapentine (3HP) plus directly observed therapy for 12 weeks.

Methods: This prospective pilot study included adult patients diagnosed with LTBI. Patients were eligible for study participation if they spoke English or Spanish and were followed by the New Mexico Department of Health (NM DOH). Patients were excluded if they were pregnant, receiving concomitant HIV antiretroviral therapy, or had contraindications to 3HP due to allergy or drug interactions. Community pharmacy sites included chain, independent, and hospital outpatient pharmacies in Albuquerque and Santa Fe, New Mexico.

Results: A total of 40 patients initiated treatment with 3HP and were included. Most were female (55%) and had a mean age of 46 years (standard deviation, 12.6 y). A total of 75.0% of patients completed LTBI treatment with 3HP in a community pharmacy site. Individuals of Hispanic ethnicity were more likely to complete treatment (76.7% vs 40.0%, P = .04). Most patients (60%; n = 24) reported experiencing an adverse drug event (ADE) with 3HP therapy. Patients who completed treatment were less likely to experience an ADE than patients who discontinued treatment (50.0% vs 90.0%, P = .03). Pharmacists performed 398 LTBI treatment visits (40 initial visits, 358 follow-up visits), saving the NM DOH approximately 143 hours in patient contact time.

Conclusion: High completion rates and safe administration of LTBI treatment can be achieved in the community pharmacy setting.

PubMed Disclaimer

Figures

Figure
Figure
Flow diagram for patient enrollment, study on using a collaborative care model to treat LTBI, New Mexico, 2017–2018. Abbreviation: LTBI, latent tuberculosis infection.

Comment in

References

    1. Global tuberculosis report 2018. World Health Organization; 2018. https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-en.... Accessed February 27, 2019.
    1. Framework towards tuberculosis elimination in low-incidence countries. World Health Organization; 2014. https://www.who.int/tb/publications/elimination_framework/en/. Accessed February 27, 2019. - PubMed
    1. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005;172(9):1169–227. 10.1164/rccm.2508001 - DOI - PubMed
    1. Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics 2015;33(9):939–55. 10.1007/s40273-015-0279-6 - DOI - PMC - PubMed
    1. Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR Jr, Marks SM, Linas BP. Cost-effectiveness of testing and treatment of latent tuberculosis infection in residents born outside of the Unites States with and without medical comorbidities in a simulation model. JAMA Intern Med 2017;177(12):1755–64. 10.1001/jamainternmed.2017.3941 - DOI - PMC - PubMed

Publication types